US Patent Issued to Jerome Canady Research Institute for Advanced Biological and Technological Sciences on Sept. 9 for "Method for cold plasma induced cell death in breast cancer cells by 8-oxoG modification and degradation of histone mRNA" (Maryland Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,484, issued on Sept. 9, was assigned to Jerome Canady Research Institute for Advanced Biological and Technological Sciences (Takoma Park, Md.).

"Method for cold plasma induced cell death in breast cancer cells by 8-oxoG modification and degradation of histone mRNA" was invented by Jerome Canady (Takoma Park, Md.), Saravana Murthy (Takoma Park, Md.), Xiaoqian Cheng (Takoma Park, Md.) and Taisen Zhuang (Takoma Park, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for inducing cell death in breast cancer regardless of subtyping through histone mRNA oxidation and degradation during the early S-phase of the cell cycle. A method for monitorin...